• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无脉络膜症:一般研究结果与发病机制综述

Choroideremia: a review of general findings and pathogenesis.

作者信息

Coussa Razek Georges, Traboulsi Elias I

机构信息

Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

出版信息

Ophthalmic Genet. 2012 Jun;33(2):57-65. doi: 10.3109/13816810.2011.620056. Epub 2011 Oct 21.

DOI:10.3109/13816810.2011.620056
PMID:22017263
Abstract

Choroideremia (CHM) is an X-linked retinal dystrophy belonging to the family of blinding disorders. It is characterized by progressive degeneration of the choriocapillaris, retinal pigment epithelium and photoreceptors. CHM is caused by mutations in the Rab Escort Protein 1 (REP-1) gene, which encodes a protein involved in vesicular trafficking. This paper gives an overview of the clinical features, visual function, biochemistry, histology, molecular genetics, pathogenesis, diagnosis and treatment of CHM.

摘要

无脉络膜症(CHM)是一种属于致盲性疾病家族的X连锁视网膜营养不良。其特征是脉络膜毛细血管、视网膜色素上皮和光感受器进行性退变。CHM由Rab护送蛋白1(REP-1)基因突变引起,该基因编码一种参与囊泡运输的蛋白质。本文概述了CHM的临床特征、视觉功能、生物化学、组织学、分子遗传学、发病机制、诊断和治疗。

相似文献

1
Choroideremia: a review of general findings and pathogenesis.无脉络膜症:一般研究结果与发病机制综述
Ophthalmic Genet. 2012 Jun;33(2):57-65. doi: 10.3109/13816810.2011.620056. Epub 2011 Oct 21.
2
Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations.脉络膜视网膜炎患者视网膜重塑:rab护送蛋白1(REP-1)突变
Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4113-20. doi: 10.1167/iovs.06-0424.
3
Molecular genetics ‎characterization and homology modeling of the CHM gene mutation: A study on its association with choroideremia.分子遗传学特征及 CHM 基因突变同源建模:与脉络膜视网膜变性相关性研究。
Mutat Res Rev Mutat Res. 2018 Jan-Mar;775:39-50. doi: 10.1016/j.mrrev.2018.02.001. Epub 2018 Feb 18.
4
Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase.全面突变分析(20 个家系)的脉络膜视网膜炎基因显示错义变体,可防止 REP1 与 Rab geranylgeranyl 转移酶结合。
Hum Mutat. 2011 Dec;32(12):1460-9. doi: 10.1002/humu.21591. Epub 2011 Oct 11.
5
Genetic study in a tunisian family revealed IVS1+1G>A mutation in the CHM gene.对一个突尼斯家庭的基因研究揭示了CHM基因中的IVS1+1G>A突变。
Ann Biol Clin (Paris). 2015 Jul-Aug;73(4):469-73. doi: 10.1684/abc.2015.1052.
6
Copy number variant analysis in CHM to detect duplications underlying choroideremia.在CHM中进行拷贝数变异分析以检测脉络膜视网膜炎潜在的重复。
Ophthalmic Genet. 2013 Dec;34(4):229-33. doi: 10.3109/13816810.2012.752016. Epub 2012 Dec 28.
7
Choroideremia: molecular mechanisms and therapies.脉络膜视网膜变性:分子机制与治疗方法。
Trends Mol Med. 2022 May;28(5):378-387. doi: 10.1016/j.molmed.2022.02.011. Epub 2022 Mar 24.
8
Whole-exome sequencing reveals a novel CHM gene mutation in a family with choroideremia initially diagnosed as retinitis pigmentosa.全外显子组测序揭示了一个最初被诊断为色素性视网膜炎的脉络膜骨瘤家族中的一种新的CHM基因突变。
BMC Ophthalmol. 2015 Jul 28;15:85. doi: 10.1186/s12886-015-0081-4.
9
Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.视网膜色素变性:临床及电生理特征的变异性及首次视网膜电图阴性报告
Ophthalmology. 2006 Nov;113(11):2066.e1-10. doi: 10.1016/j.ophtha.2006.05.045. Epub 2006 Aug 28.
10
A frameshift mutation in the CHM gene causes choroideremia with acute angle‑closure glaucoma.CHM 基因突变导致脉络膜黑色素瘤合并急性闭角型青光眼。
Mol Med Rep. 2018 Jun;17(6):7918-7924. doi: 10.3892/mmr.2018.8851. Epub 2018 Apr 5.

引用本文的文献

1
Retinal Sensitivity in Comparison to Cone Density in Choroideremia.脉络膜缺损患者视网膜敏感度与视锥细胞密度的比较
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):6. doi: 10.1167/iovs.65.14.6.
2
Retinal oxygen metabolic function in choroideremia and retinitis pigmentosa.脉络膜缺损和视网膜色素变性中的视网膜氧代谢功能。
Graefes Arch Clin Exp Ophthalmol. 2025 Feb;263(2):379-385. doi: 10.1007/s00417-024-06659-8. Epub 2024 Oct 12.
3
Glial remodeling and choroidal vascular pathology in eyes from two donors with Choroideremia.两名脉络膜视网膜萎缩症供体眼睛中的神经胶质重塑和脉络膜血管病变
Front Ophthalmol (Lausanne). 2022 Oct 14;2:994566. doi: 10.3389/fopht.2022.994566. eCollection 2022.
4
Parafoveal cone function in choroideremia assessed with adaptive optics optoretinography.用自适应光学视网膜电图评估脉络膜视网膜炎的旁中心锥功能。
Sci Rep. 2024 Apr 9;14(1):8339. doi: 10.1038/s41598-024-58059-x.
5
Using Goldmann Visual Field Volume to Track Disease Progression in Choroideremia.使用戈德曼视野容积法追踪脉络膜缺损症的疾病进展
Ophthalmol Sci. 2023 Sep 14;3(4):100397. doi: 10.1016/j.xops.2023.100397. eCollection 2023 Dec.
6
Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial.雷帕霉素靶蛋白反义寡核苷酸眼内注射治疗成年男性脉络膜视网膜炎:一项随机 3 期临床试验。
Nat Med. 2023 Oct;29(10):2464-2472. doi: 10.1038/s41591-023-02520-3. Epub 2023 Oct 9.
7
Cone Photoreceptor Morphology in Choroideremia Assessed Using Non-Confocal Split-Detection Adaptive Optics Scanning Light Ophthalmoscopy.应用非共焦分裂探测自适应光学扫描检眼镜评估色素性视网膜炎中的锥形光感受器形态。
Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):36. doi: 10.1167/iovs.64.10.36.
8
Clinical and imaging findings of choroideremia in a pediatric patient due to a novel frameshift mutation.一名儿科患者因新型移码突变导致的脉络膜视网膜萎缩的临床和影像学表现。
Am J Ophthalmol Case Rep. 2022 Oct 6;28:101718. doi: 10.1016/j.ajoc.2022.101718. eCollection 2022 Dec.
9
Widespread subclinical cellular changes revealed across a neural-epithelial-vascular complex in choroideremia using adaptive optics.利用自适应光学技术在脉络膜黑色素瘤中发现广泛的神经上皮血管复合亚临床细胞变化。
Commun Biol. 2022 Sep 13;5(1):893. doi: 10.1038/s42003-022-03842-7.
10
A Novel Hypothesis on Choroideremia-Manifesting Female Carriers: Could In-Frame Variants Exert a Dominant Negative Effect? A Case Report.脉络膜视网膜炎表现型女性携带者的新假说:框内变异体是否具有显性负效应?一例报告。
Genes (Basel). 2022 Jul 17;13(7):1268. doi: 10.3390/genes13071268.